W. Lippmann

945 total citations
71 papers, 719 citations indexed

About

W. Lippmann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, W. Lippmann has authored 71 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 16 papers in Pharmacology. Recurrent topics in W. Lippmann's work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (14 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). W. Lippmann is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (14 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). W. Lippmann collaborates with scholars based in United States and China. W. Lippmann's co-authors include Thomas A. Pugsley, J. Coppola, K. C. Kent Lloyd, Marcia Wishnick, I. Ringler, Perrine Jullien, J.N. Ball, H. Immer, Kazimir Sestanj and Jehan F. Bagli and has published in prestigious journals such as Nature, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

W. Lippmann

68 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Lippmann United States 16 222 204 178 130 86 71 719
Jake Weeks United States 12 213 1.0× 142 0.7× 250 1.4× 54 0.4× 42 0.5× 28 739
Guy P. E. Tell France 12 545 2.5× 308 1.5× 62 0.3× 117 0.9× 49 0.6× 17 1.1k
John M. Stavorski United States 11 219 1.0× 200 1.0× 60 0.3× 56 0.4× 65 0.8× 16 593
Carl T. Ludden United States 12 306 1.4× 212 1.0× 66 0.4× 52 0.4× 60 0.7× 25 766
Atsushi Nagahisa United States 19 517 2.3× 519 2.5× 127 0.7× 122 0.9× 145 1.7× 29 1.1k
F. H. Schneider United States 15 616 2.8× 368 1.8× 48 0.3× 180 1.4× 67 0.8× 26 1.2k
Jukka Tenhunen Finland 14 409 1.8× 173 0.8× 57 0.3× 84 0.6× 32 0.4× 18 1.0k
M. D. A. FINNIE United Kingdom 9 492 2.2× 487 2.4× 39 0.2× 80 0.6× 26 0.3× 14 942
H. YAJIMA Japan 14 311 1.4× 329 1.6× 23 0.1× 48 0.4× 64 0.7× 36 619
Herbert C. Wenger United States 10 263 1.2× 225 1.1× 42 0.2× 44 0.3× 47 0.5× 18 659

Countries citing papers authored by W. Lippmann

Since Specialization
Citations

This map shows the geographic impact of W. Lippmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Lippmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Lippmann more than expected).

Fields of papers citing papers by W. Lippmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Lippmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Lippmann. The network helps show where W. Lippmann may publish in the future.

Co-authorship network of co-authors of W. Lippmann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Lippmann. A scholar is included among the top collaborators of W. Lippmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Lippmann. W. Lippmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pugsley, Thomas A. & W. Lippmann. (1979). Effect of metiamide, a histamine H2-receptor antagonist on the clonidine-induced decrease in rat brain noradrenaline turnover. Journal of Pharmacy and Pharmacology. 31(1). 51–52. 5 indexed citations
2.
Lippmann, W., et al.. (1979). Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.. PubMed. 29(5). 793–8. 14 indexed citations
3.
Pugsley, Thomas A. & W. Lippmann. (1979). Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain. Journal of Pharmacy and Pharmacology. 31(1). 47–49. 1 indexed citations
4.
Lippmann, W., et al.. (1978). Effect of Alrestatin Sodium on Glucose-Stimulated Insulin Secretion in the Fasted Anaesthetized Rat. Hormone and Metabolic Research. 10(6). 495–500. 2 indexed citations
5.
Lippmann, W., et al.. (1978). Effect of Alrestatin on Arginine-Induced Secretion of Glucagon and Insulin in the Rat. Hormone and Metabolic Research. 10(4). 280–282. 3 indexed citations
6.
Pugsley, Thomas A. & W. Lippmann. (1977). Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.. PubMed. 27(12). 2293–6. 5 indexed citations
7.
Lippmann, W., et al.. (1976). Antagonism of prostaglandin-induced cyclic AMP accumulation in the rat anterior pituitary in vitro by somatostatin analogues. Cellular and Molecular Life Sciences. 32(8). 1034–1036. 12 indexed citations
8.
Pugsley, Thomas A., et al.. (1976). Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. Canadian Journal of Physiology and Pharmacology. 54(4). 510–515. 5 indexed citations
9.
Bagli, Jehan F., et al.. (1976). Synthesis and antihypertensive activity of some thienylethanolamines. Journal of Medicinal Chemistry. 19(7). 876–882. 15 indexed citations
10.
Lippmann, W.. (1975). Stimulation of cyclic AMP accumulation in the rat anterior pituitary in vitro by analogs of luteinizing hormone-releasing hormone. Cellular and Molecular Life Sciences. 31(4). 403–404. 1 indexed citations
11.
12.
13.
Lippmann, W.. (1969). Inhibition of gastric acid secretion in the rat by synthetic prostaglandins. Journal of Pharmacy and Pharmacology. 21(5). 335–336. 28 indexed citations
14.
Lippmann, W.. (1968). Relationship between Hypothalamic Norepinephrine and Serotonin and Gonadotrophin Secretion in the Hamster. Nature. 218(5137). 173–174. 18 indexed citations
15.
Lippmann, W. & Marcia Wishnick. (1968). ASPECTS OF THE BIOGENIC AMINE‐DEPLETING ACTIVITY OF ETHYL 3‐ACETAMIDO‐4H‐PYRROLO‐[3,4‐c]ISOXAZOLE‐5(6H)‐CARBOXYLATE IN THE RAT. British Journal of Pharmacology and Chemotherapy. 33(2). 257–265. 1 indexed citations
16.
Lippmann, W. & Marcia Wishnick. (1967). EFFECTS OF METHOTRIMEPRAZINE, OTHER PHENOTHIAZINES AND RELATED COMPOUNDS ON THE LEVELS OF NOREPINEPHRINE IN THE MOUSE HEART. Journal of Pharmacology and Experimental Therapeutics. 157(2). 363–370. 1 indexed citations
17.
Lippmann, W. & Marcia Wishnick. (1967). Effects of ethyl 3-acetamido-4H-pyrrolo[3, 4-c]-isoxazole-5(6H)carboxylate on tissue levels of catecholamines and 5-hydroxytryptamine in the rat. Journal of Pharmacy and Pharmacology. 19(12). 855–856. 2 indexed citations
18.
Lippmann, W., et al.. (1967). RELATIONSHIP BETWEEN HYPOTHALAMIC CATECHOLAMINES AND GONADOTROPHIN SECRETION IN RATS. Journal of Pharmacology and Experimental Therapeutics. 156(2). 258–266. 20 indexed citations
19.
Lippmann, W. & Marcia Wishnick. (1965). EFFECTS OF THE ADMINISTRATION OF EPSILON AMINO CAPROIC ACID ON CATECHOLAMINE AND SEROTONIN LEVELS IN THE RAT AND DOG. Journal of Pharmacology and Experimental Therapeutics. 150(2). 196–202. 16 indexed citations
20.
Lippmann, W. & Marcia Wishnick. (1965). Effect of Dl-p-chloro-N-methylamphetamine on the concentrations of monoamines in the cat and rat brain and rat heart. Life Sciences. 4(8). 849–857. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jake Weeks Breakdown of academic impact, for papers by Guy P. E. Tell Breakdown of academic impact, for papers by John M. Stavorski Breakdown of academic impact, for papers by Carl T. Ludden Breakdown of academic impact, for papers by Atsushi Nagahisa Breakdown of academic impact, for papers by F. H. Schneider Breakdown of academic impact, for papers by Jukka Tenhunen Breakdown of academic impact, for papers by M. D. A. FINNIE Breakdown of academic impact, for papers by H. YAJIMA Breakdown of academic impact, for papers by Herbert C. Wenger
Rankless by CCL
2026